# FDA 483 - Nexus Pharmaceuticals, LLC - November 05, 2014

Source: https://www.globalkeysolutions.net/records/483/nexus-pharmaceuticals-llc/98f2e2a3-d907-4230-9890-b8528ea9abf0

> FDA 483 for Nexus Pharmaceuticals, LLC on November 05, 2014. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Nexus Pharmaceuticals, LLC
- Inspection Date: 2014-11-05
- Product Type: drugs
- Office Name: Chicago District Office
- Summary: Nexus Pharmaceuticals Inc. in Vernon Hills, IL, was inspected regarding its role as a drug product owner and ANDA applicant holder. The inspection revealed significant deficiencies in the firm's quality control unit responsibilities for contract manufacturing and its procedures for handling drug product complaints. These issues indicate a lack of adequate oversight and investigation into product quality concerns.

## Related Documents

- [483 - 2019-11-22](https://www.globalkeysolutions.net/records/483/nexus-pharmaceuticals-llc/fa5e6e29-7911-49ca-8869-54063d19d85d)

## Related Officers

- [Senior Compliance Manager](https://www.globalkeysolutions.net/people/christina-a-miller/7893b145-2814-4443-a886-29881db45918)

Company: https://www.globalkeysolutions.net/companies/nexus-pharmaceuticals-llc/9f6c2dd9-2ee0-4492-bcaf-992ff47330cf

Office: https://www.globalkeysolutions.net/offices/chicago-district-office/a510300b-0eaf-4a33-90b5-231d95977669